Skip to main content

Table 4 Overall summary of patients with an adverse event

From: Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study

Adverse events Placebo (n = 87) Pentoxifylline (n = 87)
Overall summary of patients with an AE, n (%)   
 One or more AE, n (%) 20 (23.0) 27 (31.0)
 One or more drug-related AE, n (%) 12 (13.8) 23 (26.4)
AE leading to discontinuation 5 (5.7) 13 (14.9)
Patients with AEs of ≥3 % in any group, n (%)   
 Dyspepsia 1 (1.1) 7 (8.0)
 Nausea/vomiting 2 (2.3) 5 (5.7)
 Gastric reflux 3 (3.4) 5 (5.7)
 Diarrhea 0 (0.0) 2 (2.3)
 Constipation 0 (0.0) 1 (1.1)
 Headache 1 (1.1) 3 (3.4)
  1. AE adverse event